Antineoplastic agents, immunological Clinical Trials
Conditions / Antineoplastic agents, immunological
Delta Trials records 2 clinical trials for Antineoplastic agents, immunological in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 72 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
2
Total Trials
1
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
72
Study Locations
Browse by location (72 total)
- Pittsburgh, United States 1 trialAll trials in Pittsburgh, United States
- Villeurbanne, France 1 trialAll trials in Villeurbanne, France
- Pierre-Bénite, France 1 trialAll trials in Pierre-Bénite, France
- Pierre-Bénite, France 1 trialAll trials in Pierre-Bénite, France
- Pierre-Bénite, France 1 trialAll trials in Pierre-Bénite, France
- Bordeaux, France 1 trialAll trials in Bordeaux, France
- Neuilly-sur-Seine, France 1 trialAll trials in Neuilly-sur-Seine, France
- Lens, France 1 trialAll trials in Lens, France
- Reims, France 1 trialAll trials in Reims, France
- Beauvais, France 1 trialAll trials in Beauvais, France
- Le Puy-en-Velay, France 1 trialAll trials in Le Puy-en-Velay, France
- Compiègne, France 1 trialAll trials in Compiègne, France
- Plérin, France 1 trialAll trials in Plérin, France
- Perpignan, France 1 trialAll trials in Perpignan, France
- Lyon, France 1 trialAll trials in Lyon, France
- Versailles, France 1 trialAll trials in Versailles, France
- Chartres, France 1 trialAll trials in Chartres, France
- Beuvry, France 1 trialAll trials in Beuvry, France
- La Roche-sur-Yon, France 1 trialAll trials in La Roche-sur-Yon, France
- Créteil, France 1 trialAll trials in Créteil, France